Logo image of ABT

ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ABT - US0028241000 - Common Stock

126.13 USD
-0.91 (-0.72%)
Last: 1/8/2026, 3:27:03 PM
Fundamental Rating

6

ABT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. ABT gets an excellent profitability rating and is at the same time showing great financial health properties. ABT has a decent growth rate and is not valued too expensively. Finally ABT also has an excellent dividend rating. With these ratings, ABT could be worth investigating further for dividend and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ABT had positive earnings in the past year.
ABT had a positive operating cash flow in the past year.
ABT had positive earnings in each of the past 5 years.
Each year in the past 5 years ABT had a positive operating cash flow.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

ABT has a better Return On Assets (16.60%) than 97.30% of its industry peers.
With an excellent Return On Equity value of 27.43%, ABT belongs to the best of the industry, outperforming 98.38% of the companies in the same industry.
ABT has a better Return On Invested Capital (9.90%) than 89.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABT is in line with the industry average of 8.84%.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 9.9%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

ABT's Profit Margin of 31.88% is amongst the best of the industry. ABT outperforms 97.84% of its industry peers.
In the last couple of years the Profit Margin of ABT has grown nicely.
ABT has a Operating Margin of 18.29%. This is amongst the best in the industry. ABT outperforms 89.73% of its industry peers.
In the last couple of years the Operating Margin of ABT has grown nicely.
ABT has a Gross Margin of 56.19%. This is comparable to the rest of the industry: ABT outperforms 54.59% of its industry peers.
ABT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABT is still creating some value.
ABT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABT has been reduced compared to 5 years ago.
The debt/assets ratio for ABT has been reduced compared to a year ago.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

ABT has an Altman-Z score of 5.79. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ABT (5.79) is better than 78.92% of its industry peers.
ABT has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
ABT has a Debt to FCF ratio of 1.87. This is amongst the best in the industry. ABT outperforms 88.11% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
ABT's Debt to Equity ratio of 0.23 is in line compared to the rest of the industry. ABT outperforms 56.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.79
ROIC/WACC1.02
WACC9.7%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

ABT has a Current Ratio of 1.70. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.70, ABT is not doing good in the industry: 68.11% of the companies in the same industry are doing better.
ABT has a Quick Ratio of 1.24. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.24, ABT is doing worse than 65.95% of the companies in the same industry.
ABT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.40% over the past year.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
Looking at the last year, ABT shows a small growth in Revenue. The Revenue has grown by 6.37% in the last year.
The Revenue has been growing slightly by 5.63% on average over the past years.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%

3.2 Future

The Earnings Per Share is expected to grow by 9.89% on average over the next years. This is quite good.
ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.22% yearly.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.28, the valuation of ABT can be described as expensive.
Based on the Price/Earnings ratio, ABT is valued a bit cheaper than 77.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of ABT to the average of the S&P500 Index (26.92), we can say ABT is valued inline with the index average.
With a Price/Forward Earnings ratio of 22.00, ABT is valued on the expensive side.
ABT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ABT is cheaper than 79.46% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.57, ABT is valued at the same level.
Industry RankSector Rank
PE 25.28
Fwd PE 22
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABT indicates a somewhat cheap valuation: ABT is cheaper than 76.22% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABT indicates a somewhat cheap valuation: ABT is cheaper than 78.92% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.71
EV/EBITDA 20.26
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)2.21
PEG (5Y)3.33
EPS Next 2Y10.8%
EPS Next 3Y10.58%

7

5. Dividend

5.1 Amount

ABT has a Yearly Dividend Yield of 2.01%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 0.20, ABT pays a better dividend. On top of this ABT pays more dividend than 96.22% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, ABT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

The dividend of ABT is nicely growing with an annual growth rate of 11.40%!
ABT has paid a dividend for at least 10 years, which is a reliable track record.
ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

ABT pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
ABT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

ABBOTT LABORATORIES

NYSE:ABT (1/8/2026, 3:27:03 PM)

126.13

-0.91 (-0.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-20 2026-01-20/amc
Inst Owners81.33%
Inst Owner Change0%
Ins Owners0.45%
Ins Owner Change-0.06%
Market Cap219.32B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target146.81 (16.4%)
Short Float %0.92%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15 2026-01-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-0.04%
PT rev (3m)1.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 25.28
Fwd PE 22
P/S 5
P/FCF 31.71
P/OCF 24.05
P/B 4.3
P/tB 10.26
EV/EBITDA 20.26
EPS(TTM)4.99
EY3.96%
EPS(NY)5.73
Fwd EY4.55%
FCF(TTM)3.98
FCFY3.15%
OCF(TTM)5.24
OCFY4.16%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)2.21
PEG (5Y)3.33
Graham Number57.36
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 9.9%
ROICexc 11.13%
ROICexgc 21.33%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.79
F-Score7
WACC9.7%
ROIC/WACC1.02
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%

ABBOTT LABORATORIES / ABT FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABT.


What is the valuation status of ABBOTT LABORATORIES (ABT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


What is the profitability of ABT stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.


What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 25.28 and the Price/Book (PB) ratio is 4.3.


Can you provide the expected EPS growth for ABT stock?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.44% in the next year.